Georgina L. Eden

Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT.

Beyond platelet activation: dysregulated lipid metabolism in defining risk and pathophysiology of VITT.

Journal: Research and practice in thrombosis and haemostasis

Published: June 18, 2024

No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines.

No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines.

Journal: The Journal of clinical investigation

Published: July 20, 2023

The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

Journal: Nature communications

Published: April 05, 2023

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines.

A systems immunology study comparing innate and adaptive immune responses in adults to COVID-19 mRNA and adenovirus vectored vaccines.

Journal: Cell reports. Medicine

Published: August 22, 2022

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

Journal: EMBO molecular medicine

Published: May 28, 2021

The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.

The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota.

Journal: Cell reports. Medicine

Published: December 14, 2020

The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life.

The composition of the gut microbiota following early-life antibiotic exposure affects host health and longevity in later life.

Journal: Cell reports

Published: September 01, 2020

Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.

Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 30, 2020

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy.

Journal: British journal of cancer

Published: June 27, 2019

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.

Targeting metabolic activity in high-risk neuroblastoma through Monocarboxylate Transporter 1 (MCT1) inhibition.

Journal: Oncogene

Published: February 03, 2019

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Macrophage-Derived IL1β and TNFα Regulate Arginine Metabolism in Neuroblastoma.

Journal: Cancer research

Published: July 13, 2018

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Inhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastoma.

Journal: Science translational medicine

Published: May 16, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026